Dexamethasone sodium phosphate CAS 2392-39-4 DSP DEXAMETHASONE 21 PHOSPHATE SODIUM

We supply good quality Dexamethasone sodium phosphate CAS 2392-39-4

Introduction

Dexamethasone Sodium Phosphate is a systemic corticosteroid. Dexamethasone Sodium Phosphate induces apoptosis and inhibits sodium phosphate symporter. Dexamethasone Sodium Phosphate is also used in the treatment of emetic effects of cancer therapy and epicondylitis. Dexamethasone Sodium Phosphate is an activator of GR.

Dexamethasone is a potent synthetic member of the glucocorticoid class of steroid drugs. It acts as an anti-inflammatory and immunosuppressant.Adrenocorticotropic hormone drugs, anti-inflammatory, anti-allergic and anti-drug more effective than prednisone, and promoting the removal of potassium sodium retention is very light, intramuscular or intravenous pituitary - adrenal strong inhibition.

Function

Dexamethasone sodium phosphate is a synthetic adrenocortical steroid used to treat inflammatory and autoimmune conditions;

•  Dexamethasone sodium phosphate is used to treat conditions such as skin conditions, ulcerative colitis, psoriasis, arthritis, allergic disorders and breathing related problems;
•  Dexamethasone sodium phosphate is given to cancer patients undergoing chemotherapy, to prevent certain side-effects:
•  Dexamethasone sodium phosphate is also used in the treatment of high altitude cerebral edema.

Application

1. Anti-inflammatory effects: The product can reduce and prevent tissue response to inflammation,

thereby reducing inflammation performance. Hormone suppression of inflammatory cells,including leukocytes and macrophages accumulation in sites of inflammation and inhibition of phagocytosis,

lysosomal enzyme release and synthesis and release of inflammatory chemical mediators.Can reduce and prevent tissue response to inflammation, thereby reducing inflammation performance.

2. Immunosuppressive effect: preventing or inhibiting cell-mediated immune response, delayed hypersensitivity reactions, reducing T lymphocytes, monocytes, eosinophils, reducing immunoglobulin binding to cell surface receptors and inhibition of the synthesis and release of interleukin, thus reducing the T lymphocyte transformation of lymphoblastoid cells, and reduce the extension of the primary immune response.Can reduce immune complexes through the basement membrane, and can reduce the concentration of ingredients complement and immunoglobulins.

Basic information

COA